Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune hepatitis in children.

Robert H Squires1

  • 1Division of Gastroenterology/Hepatology, Children's Hospital of Pittsburgh and the University of Pittsburgh Medical Center, 3705 Fifth Avenue, Pittsburgh, PA 15213, USA. Robert.squires@chp.edu

Current Gastroenterology Reports
|May 7, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

The lancet. Gastroenterology & hepatology·2024
Same author

Improved mortality prediction for pediatric acute liver failure using dynamic prediction strategy.

Journal of pediatric gastroenterology and nutrition·2024
Same author

Neonatal cholestasis in children with Alpha-1-AT deficiency is a risk for earlier severe liver disease with male predominance.

Hepatology communications·2023
Same author

Clinical spectrum and genetic causes of mitochondrial hepatopathy phenotype in children.

Hepatology communications·2023
Same author

Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study.

Hepatology communications·2023
Same author

Assessing predictive discrimination performance of biomarkers in the presence of treatment-induced dependent censoring.

Journal of the Royal Statistical Society. Series C, Applied statistics·2022

Autoimmune hepatitis (AIH) in children presents a wide spectrum of illness. Diagnosis requires specific markers and evidence of liver injury, with treatment involving immunosuppressants to reverse the course.

Area of Science:

  • Pediatric Hepatology
  • Immunology

Background:

  • Autoimmune hepatitis (AIH) is a complex pediatric liver disease with an incompletely understood pathophysiology, partly due to the absence of a spontaneous animal model.
  • The clinical presentation of AIH in children varies significantly, from asymptomatic aminotransferase elevations to acute liver failure.

Purpose of the Study:

  • To summarize the current understanding of autoimmune hepatitis (AIH) in children, including diagnosis, clinical spectrum, and treatment.

Main Methods:

  • Review of existing literature on autoimmune hepatitis in pediatric populations.
  • Analysis of diagnostic criteria, clinical presentations, and treatment outcomes.

Main Results:

  • Diagnosis relies on serum autoimmune markers, biochemical and histologic evidence of hepatocellular injury, excluding other causes.

Related Experiment Videos

  • AIH Type 1 is associated with older age and cirrhosis, while Type 2 can be more fulminant and require long-term immunosuppression.
  • Treatment with prednisone and azathioprine is effective in reversing clinical and biochemical abnormalities.

    • Conclusions:

    • AIH in children requires a comprehensive diagnostic approach and tailored immunosuppressive therapy.
    • While treatment is effective, potential recurrence in liver allografts necessitates ongoing monitoring.